Full Length Transmembrane Proteins
SKU: FLP100006 Target: CLDN18.2
Price: 50 μg $1200.00 ; 100 μg $1600.00
Full Length Transmembrane Proteins
SKU: FLP200014 Target: CLDN18.2
Price: 50 μg $1200.00 ; 100 μg $1600.00
Full Length Transmembrane Proteins
SKU: FLP100014 Target: CLDN18.2
Price: 10 μg $900.00 ; 50 μg $4400.00 ; 100 μg $8000.00
Full Length Transmembrane Proteins
SKU: FLP120014 Target: CLDN18.2
Price: 10 μg $810.00 ; 50 μg $3960.00 ; 100 μg $7200.00
Full Length Transmembrane Proteins
Biotinylated Human CLDN18.2 full length protein-synthetic nanodisc
SKU: FLP100014B Target: CLDN18.2
Price: 10 μg $990.00 ; 50 μg $4840.00 ; 100 μg $8800.00
Full Length Transmembrane Proteins
SKU: FLP100017 Target: CLDN18.2
Price: 25test $180.00 ; 100test $530.00
Posts found
CLDN6, the next promising target for solid tumor therapy after ClDN18.2?
In June 2023, BioNTech presented the first human trial data of BNT211 at the American Society [...]
Aug
Emerging Trends: ADC Drug Targets to Watch at ASCO 2024
The 2024 American Society of Clinical Oncology Annual Meeting (ASCO 2024) will take place in [...]
May
Navigating the ADC Frontier: Unleashing the Magic of Antibody-Drug Conjugates
Antibody-drug conjugates (ADCs) have been one of the hottest areas in the biopharmaceutical industry in [...]
Apr
Tumor Immune Target – Claudin18.2
Since Ganymed unveiled the efficacy data of Zolbetuximab (IMAB362), the anti-Claudin18.2 monoclonal antibody, for the [...]
Apr
Unraveling the Mystery of ‘Million-Dollar’ CAR-T Therapy
In 2012, a young girl named Emily Whitehead, suffering from acute lymphoblastic leukemia, became the [...]
Oct